JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (BKK:JSP)
Thailand flag Thailand · Delayed Price · Currency is THB
1.780
-0.020 (-1.11%)
Aug 11, 2026, 1:58 PM ICT

BKK:JSP Balance Sheet

Millions THB. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
46.4448.0329.4920.65100.2623.9
Trading Asset Securities
----209.8127
Cash & Short-Term Investments
46.4448.0329.4920.65310.01650.9
Cash Growth
27.95%62.87%42.78%-93.34%-52.37%132077.56%
Accounts Receivable
144.61151.38116.5487.9279.5130.91
Other Receivables
30.2726.8138.6434.7127.8932.14
Receivables
174.88178.19160.18122.63107.463.05
Inventory
129.22101.44122.42102.1599.37109.48
Other Current Assets
--0.190.181.250.72
Total Current Assets
350.55327.66312.28245.61518.02824.15
Property, Plant & Equipment
1,0601,072905.47865.36670.23396.54
Long-Term Investments
--13.63132.725.99-
Goodwill
32.5532.5532.5532.55--
Other Intangible Assets
4.394.515.456.225.384.51
Long-Term Accounts Receivable
----7.3-
Long-Term Deferred Tax Assets
19.4317.9147.422.0330.2415.88
Long-Term Deferred Charges
--0.240.730.680.21
Other Long-Term Assets
10.819.149.6327.1824.9919.35
Total Assets
1,4781,4641,3271,3371,3671,261

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
58.8545.8453.4543.6546.2140.27
Accrued Expenses
1.527.843.921.811.66-
Short-Term Debt
84.9952.8456.8687.7119.39-
Current Portion of Long-Term Debt
44.7344.3528.0710.5310.0612.87
Current Portion of Leases
13.8811.9217.8810.368.062.86
Current Income Taxes Payable
13.1410.9117.06-2.74-
Current Unearned Revenue
13.0515.4413.7611.1626.8929.52
Other Current Liabilities
33.1547.3937.4429.592729.09
Total Current Liabilities
263.31236.54228.45194.8142114.61
Long-Term Debt
221.17232.595056.2737.6269.63
Long-Term Leases
37.1939.47135.6125.67113.9998.09
Long-Term Unearned Revenue
6.76.638.8410.699.951.29
Pension & Post-Retirement Benefits
20.5719.9319.7716.5913.3810.59
Long-Term Deferred Tax Liabilities
0.10.160.270.39--
Other Long-Term Liabilities
1.261.251.21.16--
Total Liabilities
550.31536.56444.13405.57316.94294.21

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
237.29237.29237.29237.28227.5227.5
Additional Paid-In Capital
722.93722.93772.53772.49733.46733.46
Retained Earnings
71.1970.74-21.47-9.81-7.417
Comprehensive Income & Other
-125.12-122.35-130.35-130.3596.01-11.54
Total Common Equity
906.29908.61858869.611,050966.43
Minority Interest
21.5518.3924.5262.220-
Shareholders' Equity
927.84927882.52931.831,050966.43
Total Liabilities & Equity
1,4781,4641,3271,3371,3671,261

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
401.97381.17288.41290.53189.12183.45
Net Cash (Debt)
-355.53-333.14-258.92-269.88120.89467.46
Net Cash Growth
-----74.14%-
Net Cash Per Share
-0.76-0.70-0.55-0.580.251.30
Filing Date Shares Outstanding
474.57474.58474.58474.56455455
Total Common Shares Outstanding
474.57474.58474.58474.56455455
Working Capital
87.2391.1283.8250.81376.02709.54
Book Value Per Share
1.911.911.811.832.312.12
Tangible Book Value
869.35871.54819.99830.841,044961.91
Tangible Book Value Per Share
1.831.841.731.752.292.11
Land
-475.54227.84227.84187.52165.09
Buildings
-526.27504.2435.32219.8177.78
Machinery
-347.67339.6268.71190.54119.75
Construction In Progress
---42.78159.177.66